European Electroceuticals Market

European Electroceuticals Market Size, Share & Trends Analysis Report by Product (Cardioverter Defibrillators and Cardiac Pacemaker, Deep Brain Stimulators, Spinal Cord Stimulators, Vagus Nerve Stimulators, Cochlear Implants, and Others (Sacral Nerve Stimulators, Transcutaneous Electrical Nerve Stimulators)), by End-User (Hospitals and Clinics, and Homecare and Other), Forecast Period 2019-2025
    Update Available - Forecast 2024-2030   

Published: Jan 2020 | Report Code: OMR2020252 | Category : Medical Devices | Delivery Format: /

The European electroceuticals market is expected to grow at a CAGR of 7.0% during the forecast period. The market is growing owing to the well-developed healthcare infrastructure and supportive government policies such as the Affordable Care Act. Furthermore, the presence of favorable reimbursement policies also estimated to drive the growth of the market in the region. Rising geriatric population is another major factor that is expected to surge the market growth during the forecast period. The elderly population is at increased risk of developing various diseases such as Parkinson's disease, Alzheimer's, Cardiac arrhythmias, and epilepsy.

The market is segmented on the basis of product and end-user. On the basis of product, the market is segmented into cardioverter defibrillators and cardiac pacemaker, deep brain stimulators (DBS), spinal cord stimulators (SCS), vagus nerve stimulators, hearing aids, and cochlear implants, and others such as sacral nerve stimulators, and transcutaneous electrical nerve stimulators. By the End-user segment, the market is segmented into hospitals & clinics and home care and others. Abbott Laboratories Inc., Advanced Bionics AG, Axonics Modulation Technologies Inc., Boston Scientific Corp., BioElectronics Corp., Cochlear Ltd. are the manufacturer, and supplier of medical devices such as a pacemaker, defibrillator, vagus nerve stimulators and has its facilities in more than 40 countries and includes over 100 brands in its product portfolio. 

These players adopt various strategies in order to remain competitive in the global market. Some of the strategies followed by market players include mergers and acquisitions, product offering expansion, geographical expansion, and partnerships and collaborations. For instance, In August 2018, Demant A/S and Phillips signed an agreement for the introduction of the new and advance Phillips-branded solutions to hearing healthcare. This partnership will create various new and unique opportunities for hearing care professionals in an ever-evolving market. 

Research Methodology

The market study of the European electroceuticals market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  1. European Electroceuticals Market Research and Analysis by Product 
  2. European Electroceuticals Market Research and Analysis by End-User

The Report Covers

  • Comprehensive research methodology of the European electroceuticals market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the European electroceuticals market.
  • Insights about market determinants which are stimulating the European electroceuticals market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Geography

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis 

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. Overview

3.3.2. Financial Analysis

3.3.3. SWOT Analysis

3.3.4. Recent Developments

4. Market Determinants 

4.1. Motivators

4.2. Restraints

4.3. Opportunities 

5. Market Segmentation

5.1. European Electroceuticals Market by Product and its Application

5.1.1. Cardioverter Defibrillators and Cardiac Pacemaker

5.1.1.1. Arrhythmias

5.1.2. Deep Brain Stimulators

5.1.2.1. Parkinson’s Disease

5.1.2.2. Depression

5.1.3. Spinal Cord Stimulators

5.1.3.1. Failed Back Syndrome

5.1.3.2. Ischemia

5.1.4. Vagus Nerve Stimulators

5.1.4.1. Epilepsy

5.1.5. Cochlear Implants

5.1.5.1. Sensorineural Hearing Loss

5.1.6. Others (Sacral Nerve Stimulators, Transcutaneous Electrical Nerve Stimulators)

5.1.6.1. Urinary Incontinence

5.1.6.2. Treatment-Resistant Depression

5.2. European Electroceuticals Market by End-Users

5.2.1. Hospitals and Clinics

5.2.2. Homecare and Other

6. Regional Analysis

6.1. Germany

6.2. UK

6.3. France

6.4. Italy

6.5. Spain

6.6. Rest of Europe

7. Company Profiles

7.1. Abbott Laboratories, Inc.

7.2. Advanced Bionics AG

7.3. Boston Scientific Corp.

7.4. Cochlear, Ltd.

7.5. Demant A/S

7.6. Edwards Lifesciences Corp.

7.7. Getinge AB

7.8. GlaxoSmithKline PLC

7.9. Medtronic PLC

7.10. Sonova Holding AG

1. EUROPEAN ELECTROCEUTICALS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)

2. EUROPEAN ELECTROCEUTICALS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION) 

3. EUROPEAN ELECTROCEUTICALS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

1. EUROPEAN ELECTROCEUTICALS MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)

2. EUROPEAN ELECTROCEUTICALS MARKET SHARE BY END-USER, 2018 VS 2025 (%)

3. EUROPEAN ELECTROCEUTICALS MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)

4. GERMANY ELECTROCEUTICALS MARKET SHARE BY END-USER INDUSTRY, 2018-2025 ($ MILLION)

5. UK ELECTROCEUTICALS MARKET SHARE BY END-USER INDUSTRY, 2018-2025 ($ MILLION)

6. FRANCE ELECTROCEUTICALS MARKET SHARE BY END-USER INDUSTRY, 2018-2025 ($ MILLION)

7. ITALY ELECTROCEUTICALS MARKET SHARE BY END-USER INDUSTRY, 2018-2025 ($ MILLION)

8. SPAIN ELECTROCEUTICALS MARKET SHARE BY END-USER INDUSTRY, 2018-2025 ($ MILLION)

9. REST OF EUROPE ELECTROCEUTICALS MARKET SHARE BY END-USER INDUSTRY, 2018-2025 ($ MILLION)